.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Modern radiotherapy faces significant challenges when optimizing VMAT breast cancer planning for patients with extensive lymph node involvement. A recent international study led by the European Federation of Organisations for Medical Physics surveyed 25 participants to identify effective strategies. Consequently, this investigation provides valuable insights into clinical practices across various institutions. By examining diverse planning routines, the research highlights the need for standardized protocols in managing these complex scenarios.
The study results revealed a wide variation in beam geometry and dose constraints. For instance, mean heart doses ranged significantly from 1.5 to 9.5 Gy. Additionally, ipsilateral lung doses varied between 12.0 and 17.3 Gy. These differences underscore how institutional priorities influence the balance between target coverage and organ sparing. Furthermore, the survey covered critical topics such as simultaneous integrated boost (SIB) prescriptions and organs at risk (OAR) prioritization.
Researchers presented five specific planning strategies that achieved high target coverage while maintaining the lowest doses to critical organs. Specifically, these methods successfully optimized the dose to the breast and lymph node volumes without compromising the safety of the heart and lungs. Because clinical goals often conflict, these proven strategies offer a roadmap for planners. Therefore, adopting these techniques can improve the consistency and quality of radiation therapy for breast cancer patients worldwide.
The main challenge involves achieving adequate dose coverage for both the breast and regional lymph nodes while minimizing radiation exposure to the heart and lungs. Standardizing these goals across different institutions remains difficult.
The study found that mean heart doses varied from 1.5 Gy to 9.5 Gy, reflecting significant differences in institutional priorities and planning techniques.
An SIB is a technique where clinicians deliver a higher dose of radiation to the tumor site while the rest of the breast receives a standard dose, all within the same treatment session.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
An international study explores VMAT treatment planning for breast cancer with lymph node involvement. It identifies five effective strategies to balance high target coverage with the protection of organs at risk like the heart and lungs, addressing wide variations in clinical practice.
2 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
